arg-3-hyp-7-phe-bradykinin has been researched along with methoctramine in 1 studies
Studies (arg-3-hyp-7-phe-bradykinin) | Trials (arg-3-hyp-7-phe-bradykinin) | Recent Studies (post-2010) (arg-3-hyp-7-phe-bradykinin) | Studies (methoctramine) | Trials (methoctramine) | Recent Studies (post-2010) (methoctramine) |
---|---|---|---|---|---|
52 | 2 | 3 | 332 | 1 | 32 |
Protein | Taxonomy | arg-3-hyp-7-phe-bradykinin (IC50) | methoctramine (IC50) |
---|---|---|---|
Cholinesterase | Homo sapiens (human) | 0.9772 | |
Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.0315 | |
Acetylcholinesterase | Homo sapiens (human) | 5.3703 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
1 other study(ies) available for arg-3-hyp-7-phe-bradykinin and methoctramine
Article | Year |
---|---|
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |